56 research outputs found

    Lack of impact of the ALDH2 rs671 variant on breast cancer development in Japanese BRCA1/2‐mutation carriers

    Get PDF
    The aldehyde degrading function of the ALDH2 enzyme is impaired by Glu504Lys polymorphisms (rs671, termed A allele), which causes alcohol flushing in east Asians, and elevates the risk of esophageal cancer among habitual drinkers. Recent studies suggested that the ALDH2 variant may lead to higher levels of DNA damage caused by endogenously generated aldehydes. This can be a threat to genome stability and/or cell viability in a synthetic manner in DNA repair-defective settings such as Fanconi anemia (FA). FA is an inherited bone marrow failure syndrome caused by defects in any one of so far identified 22 FANC genes including hereditary breast and ovarian cancer (HBOC) genes BRCA1 and BRCA2. We have previously reported that the progression of FA phenotypes is accelerated with the ALDH2 rs671 genotype. Individuals with HBOC are heterozygously mutated in either BRCA1 or BRCA2, and the cancer-initiating cells in these patients usually undergo loss of the wild-type BRCA1/2 allele, leading to homologous recombination defects. Therefore, we hypothesized that the ALDH2 genotypes may impact breast cancer development in BRCA1/2 mutant carriers. We genotyped ALDH2 in 103 HBOC patients recruited from multiple cancer centers in Japan. However, we were not able to detect any significant differences in clinical stages, histopathological classification, or age at clinical diagnosis across the ALDH2 genotypes. Unlike the effects in hematopoietic cells of FA, our current data suggest that there is no impact of the loss of ALDH2 function in cancer initiation and development in breast epithelium of HBOC patients

    Acute Insulin Stimulation Induces Phosphorylation of the Na-Cl Cotransporter in Cultured Distal mpkDCT Cells and Mouse Kidney

    Get PDF
    The NaCl cotransporter (NCC) is essential for sodium reabsorption at the distal convoluted tubules (DCT), and its phosphorylation increases its transport activity and apical membrane localization. Although insulin has been reported to increase sodium reabsorption in the kidney, the linkage between insulin and NCC phosphorylation has not yet been investigated. This study examined whether insulin regulates NCC phosphorylation. In cultured mpkDCT cells, insulin increased phosphorylation of STE20/SPS1-related proline-alanine-rich kinase (SPAK) and NCC in a dose-dependent manner. This insulin-induced phosphorylation of NCC was suppressed in WNK4 and SPAK knockdown cells. In addition, Ly294002, a PI3K inhibitor, decreased the insulin effect on SPAK and NCC phosphorylation, indicating that insulin induces phosphorylation of SPAK and NCC through PI3K and WNK4 in mpkDCT cells. Moreover, acute insulin administration to mice increased phosphorylation of oxidative stress-responsive kinase-1 (OSR1), SPAK and NCC in the kidney. Time-course experiments in mpkDCT cells and mice suggested that SPAK is upstream of NCC in this insulin-induced NCC phosphorylation mechanism, which was confirmed by the lack of insulin-induced NCC phosphorylation in SPAK knockout mice. Moreover, insulin administration to WNK4 hypomorphic mice did not increase phosphorylation of OSR1, SPAK and NCC in the kidney, suggesting that WNK4 is also involved in the insulin-induced OSR1, SPAK and NCC phosphorylation mechanism in vivo. The present results demonstrated that insulin is a potent regulator of NCC phosphorylation in the kidney, and that WNK4 and SPAK are involved in this mechanism of NCC phosphorylation by insulin

    A pH-Adjustable Tissue Clearing Solution That Preserves Lipid Ultrastructures: Suitable Tissue Clearing Method for DDS Evaluation

    Get PDF
    Visualizing biological events and states to resolve biological questions is challenging. Tissue clearing permits three-dimensional multicolor imaging. Here, we describe a pH-adjustable tissue clearing solution, Seebest (SEE Biological Events and States in Tissues), which preserves lipid ultrastructures at an electron microscopy level. Adoption of polyethylenimine was required for a wide pH range adjustment of the tissue clearing solution.The combination of polyethylenimine and urea had a good tissue clearing ability for multiple tissues within several hours. Blood vessels stained with lipophilic carbocyanine dyes were deeply visible using the solution. Adjusting the pH of the solution was important to maximize the fluorescent intensity and suppress dye leakage during tissue clearing. The spatial distribution of doxorubicin and oxidative stress were observable using the solution. Moreover, spatial distribution of liposomes in the liver was visualized. Hence, the Seebest solution provides pH-adjustable, rapid, sufficient tissue clearing, while preserving lipid ultrastructures, which is suitable for drug delivery system evaluations

    çœ‹è­·ć­Šç”Ÿă«ă‚ˆă‚‹è‡šćœ°ćźŸçż’æŒ‡ć°Žăźè©•äŸĄ : 歩生ぼç‰čæ€§ă«ç„Šç‚čをあどど

    Get PDF
    ă“ă‚ŒăŸă§43項盼からăȘるEffective Clinical Teaching Behaviors(ECTB)è©•äŸĄă‚čă‚±ăƒŒăƒ«ă‚’ç”šă„ăŠç¶™ç¶šă—ăŠćźŸçż’æŒ‡ć°Žă«ćŻŸă™ă‚‹ć­Šç”Ÿăźè©•äŸĄă‚’èȘżæŸ»ăƒ»ćˆ†æžă‚’èĄŒăŁăŠăăŸ.2008ćčŽă«é ˜ćŸŸćˆ„ćźŸçż’ă‚’èĄŒăŁăŸć­Šç”ŸăźèȘżæŸ»ă§ăŻ,è‡šćœ°ćźŸçż’æŒ‡ć°Žè©•äŸĄăźćŸ—ç‚čăŒäžŠæ˜‡ă—,ćźŸçż’æŒ‡ć°Žă‚’è‚Żćźšçš„ă«ć—ă‘æ­ąă‚ăŠă„ăŸ.しかし,搌じ漟習郹çœČă§ć±•é–‹ă—ăŸă‚‚ăźăź,2009ćčŽă«é ˜ćŸŸćˆ„ćźŸçż’ă‚’èĄŒăŁăŸć­Šç”Ÿăźè‡šćœ°ćźŸçż’æŒ‡ć°Žè©•äŸĄăźćŸ—ç‚čăŻäœŽäž‹ă—ăŸ.2009ćčŽă«é ˜ćŸŸćˆ„ćźŸçż’ă‚’èĄŒăŁăŸć­Šç”ŸăźECTBăźç”æžœăŻćźŸçż’æŒ‡ć°Žè©•äŸĄăŒć…šäœ“çš„ă«äœŽäž‹ć‚Ÿć‘ă‚’ç€șし,ćźŸçż’æŒ‡ć°ŽăźćŠčæžœă‚’äžŠă’ă‚‹ăŸă‚ă«ăŻ,ă“ă‚ŒăŸă§ä»„äžŠă«ć­Šç”Ÿăźç‰čæ€§ă«é…æ…źă—ăŸćźŸçż’æŒ‡ć°Žă‚’èĄŒă†ćż…èŠăŒă‚ă‚‹ăšè€ƒăˆăŸ.çœ‹è­·ć­Šç”Ÿăźă‚šă‚Žă‚°ăƒ©ăƒ ăźăƒ‘ă‚żăƒŒăƒłăŻ4ćčŽé–“ă§ăŻć€§ăăć€‰ćŒ–ă—ăȘいべçšČ慉はいっどいるこべから,2ćčŽæŹĄă«ćźŸæ–œă•ă‚ŒăŸć­Šç”Ÿăźç‰č性èȘżæŸ»(仄䞋PC-TOAKべいう)ăšé ˜ćŸŸćˆ„ćźŸçż’ç”‚äș†ćŸŒăźECTBèȘżæŸ»ăźç”æžœă‹ă‚‰,ć­Šç”ŸăŒćźŸçż’æŒ‡ć°Žă‚’ă©ăźă‚ˆă†ă«ć—ă‘æ­ąă‚ăŸă‹,歩生ぼç‰čæ€§ă‚’ćˆă‚ă›ăŠćˆ†æžă—ăŸ.成äșșçœ‹è­·ć­ŠćźŸçż’ăźă†ăĄæ…ąæ€§æœŸăƒ»ç”‚æœ«æœŸă‚’ćźŸçż’ă—ăŸć­Šç”Ÿă«ă‚ˆă‚‹çœ‹è­·ćž«(ä»„ćŸŒæŒ‡ć°Žè€…ăšă„ă†)ăźćźŸçż’æŒ‡ć°Žè©•äŸĄă‚’æŻ”èŒƒăƒ»ćˆ†æžă—,ä»„äž‹ăźă“ăšăŒç€ș攆された.2008ćčŽăš2009ćčŽă«é ˜ćŸŸćˆ„ćźŸçż’ă‚’èĄŒăŁăŸć­Šç”ŸăŻ,ăšă‚‚ă«ćŽłæ Œă§èŠćŸ‹ă‚’é‡ă‚“ă˜ă‚‹CP,äș‹ćźŸă‚’ćźąèŠłçš„ă«ćˆ†æžă—ć†·é™ă«ćˆ€æ–­ă™ă‚‹AăŒäœŽă,äșșă«é †ćżœă™ă‚‹ACăŒé«˜ăăȘっどいた.ACăŒé«˜ăCP・AăŒäœŽă„ć­Šç”ŸăŻ,è‡Șç™șæ€§ăŒäčă—ăçŠ¶æłă«é©ćżœă—ăȘăŒă‚‰ćźŸçż’ă‚’ć±•é–‹ă™ă‚‹ăźăŒć›°é›Łă§ă‚ă‚‹ăŸă‚,ć­Šçż’èĄŒć‹•ăŒăšă‚Œă‚‹ă‚ˆă†ć…·äœ“çš„ă«ć­Šçż’æ–čæł•ă‚’æŒ‡ç€șă—ăŠçŸ„è­˜ă‚„ć­Šçż’çŠ¶æłă‚’çąșèȘă—,ć­Šç”Ÿăźć­Šăłă‚’è‚Żćźšçš„ă«è©•äŸĄă—ăŠè‡ȘäżĄă‚„é”æˆæ„Ÿă‚’ă‚‚ăŸă›ă‚‹æŒ‡ć°Žæ–čæł•ăźć·„ć€«ă‚’ă™ă‚‹ă“ăšăŒćż…èŠă§ă‚ă‚‹

    Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers

    Get PDF
    <p>Abstract</p> <p>Background</p> <p>Protease activated receptor-2 (PAR-2) has been implicated in cellular proliferation, invasion and metastasis in various tumors. Lymph node metastasis is an important patient prognostic factor for uterine cervical cancers. This prompted us to study the role of PAR-2 in lymph node metastasis of uterine cervical cancers.</p> <p>Methods</p> <p>Thirty patients underwent surgery for uterine cervical cancers. PAR-2 histoscores and mRNA levels were determined by immunohistochemistry and real-time reverse transcription-polymerase chain reaction, respectively. Patient prognosis was analyzed with a 48-month survival rate.</p> <p>Results</p> <p>PAR-2 histoscores and mRNA levels significantly (<it>P </it>< 0.05) increased in 12 of 30 metastatic lymph node lesions from the corresponding primary tumor. The 48-month survival rate of the 12 patients with increased PAR-2 levels in metastatic lymph nodes was 42%, while the rate of the other 18 patients with no change in PAR-2 levels was 82%, regardless of histopathological type.</p> <p>Conclusion</p> <p>PAR-2 might work on lymph node metastasis of uterine cervical cancers, and is considered to be a novel prognostic indicator for uterine cervical cancers.</p

    The whole blood transcriptional regulation landscape in 465 COVID-19 infected samples from Japan COVID-19 Task Force

    Get PDF
    ă€Œă‚łăƒ­ăƒŠćˆ¶ćœ§ă‚żă‚čă‚Żăƒ•ă‚©ăƒŒă‚č」COVID-19æ‚Łè€…ç”±æ„ăźèĄ€æ¶ČçŽ°èƒžă«ăŠă‘ă‚‹éșäŒć­ç™șçŸăźç¶ČçŸ…çš„è§Łæž --重症ćșŠă«ćżœă˜ăŸéșäŒć­ç™șçŸăźć€‰ćŒ–ă«ăŻă€ăƒ’ăƒˆă‚Čノム配戗ぼ怋äșșć·źăŒćœ±éŸżă™ă‚‹--. äșŹéƒœć€§ć­Šăƒ—ăƒŹă‚čăƒȘăƒȘăƒŒă‚č. 2022-08-23.Coronavirus disease 2019 (COVID-19) is a recently-emerged infectious disease that has caused millions of deaths, where comprehensive understanding of disease mechanisms is still unestablished. In particular, studies of gene expression dynamics and regulation landscape in COVID-19 infected individuals are limited. Here, we report on a thorough analysis of whole blood RNA-seq data from 465 genotyped samples from the Japan COVID-19 Task Force, including 359 severe and 106 non-severe COVID-19 cases. We discover 1169 putative causal expression quantitative trait loci (eQTLs) including 34 possible colocalizations with biobank fine-mapping results of hematopoietic traits in a Japanese population, 1549 putative causal splice QTLs (sQTLs; e.g. two independent sQTLs at TOR1AIP1), as well as biologically interpretable trans-eQTL examples (e.g., REST and STING1), all fine-mapped at single variant resolution. We perform differential gene expression analysis to elucidate 198 genes with increased expression in severe COVID-19 cases and enriched for innate immune-related functions. Finally, we evaluate the limited but non-zero effect of COVID-19 phenotype on eQTL discovery, and highlight the presence of COVID-19 severity-interaction eQTLs (ieQTLs; e.g., CLEC4C and MYBL2). Our study provides a comprehensive catalog of whole blood regulatory variants in Japanese, as well as a reference for transcriptional landscapes in response to COVID-19 infection

    DOCK2 is involved in the host genetics and biology of severe COVID-19

    Get PDF
    ă€Œă‚łăƒ­ăƒŠćˆ¶ćœ§ă‚żă‚čă‚Żăƒ•ă‚©ăƒŒă‚č」COVID-19ç–Ÿæ‚Łæ„Ÿć—æ€§éșäŒć­DOCK2ăźé‡ç—‡ćŒ–æ©Ÿćșă‚’è§Łæ˜Ž --ă‚ąă‚žă‚ąæœ€ć€§ăźăƒă‚€ă‚ȘレポゾトăƒȘăƒŒă§COVID-19たæČ»ç™‚æš™çš„ă‚’ç™ș芋--. äșŹéƒœć€§ć­Šăƒ—ăƒŹă‚čăƒȘăƒȘăƒŒă‚č. 2022-08-10.Identifying the host genetic factors underlying severe COVID-19 is an emerging challenge. Here we conducted a genome-wide association study (GWAS) involving 2, 393 cases of COVID-19 in a cohort of Japanese individuals collected during the initial waves of the pandemic, with 3, 289 unaffected controls. We identified a variant on chromosome 5 at 5q35 (rs60200309-A), close to the dedicator of cytokinesis 2 gene (DOCK2), which was associated with severe COVID-19 in patients less than 65 years of age. This risk allele was prevalent in East Asian individuals but rare in Europeans, highlighting the value of genome-wide association studies in non-European populations. RNA-sequencing analysis of 473 bulk peripheral blood samples identified decreased expression of DOCK2 associated with the risk allele in these younger patients. DOCK2 expression was suppressed in patients with severe cases of COVID-19. Single-cell RNA-sequencing analysis (n = 61 individuals) identified cell-type-specific downregulation of DOCK2 and a COVID-19-specific decreasing effect of the risk allele on DOCK2 expression in non-classical monocytes. Immunohistochemistry of lung specimens from patients with severe COVID-19 pneumonia showed suppressed DOCK2 expression. Moreover, inhibition of DOCK2 function with CPYPP increased the severity of pneumonia in a Syrian hamster model of SARS-CoV-2 infection, characterized by weight loss, lung oedema, enhanced viral loads, impaired macrophage recruitment and dysregulated type I interferon responses. We conclude that DOCK2 has an important role in the host immune response to SARS-CoV-2 infection and the development of severe COVID-19, and could be further explored as a potential biomarker and/or therapeutic target

    Finishing the euchromatic sequence of the human genome

    Get PDF
    The sequence of the human genome encodes the genetic instructions for human physiology, as well as rich information about human evolution. In 2001, the International Human Genome Sequencing Consortium reported a draft sequence of the euchromatic portion of the human genome. Since then, the international collaboration has worked to convert this draft into a genome sequence with high accuracy and nearly complete coverage. Here, we report the result of this finishing process. The current genome sequence (Build 35) contains 2.85 billion nucleotides interrupted by only 341 gaps. It covers ∌99% of the euchromatic genome and is accurate to an error rate of ∌1 event per 100,000 bases. Many of the remaining euchromatic gaps are associated with segmental duplications and will require focused work with new methods. The near-complete sequence, the first for a vertebrate, greatly improves the precision of biological analyses of the human genome including studies of gene number, birth and death. Notably, the human enome seems to encode only 20,000-25,000 protein-coding genes. The genome sequence reported here should serve as a firm foundation for biomedical research in the decades ahead
    • 

    corecore